Semax

Semax is a short fragment of ACTH with the hormonal activity removed, leaving effects on the brain. It shares a research lineage with Selank and the same regulatory situation: a registered medicine in Russia.

What it is used for in Russia and what it is sold for elsewhere are two quite different things, and that gap is the most useful thing to understand about it.

Why people are talking about it#

Because the clinical use is serious. In Russia it is given after ischaemic stroke and for cognitive disorders, which is a considerably weightier application than the focus-spray marketing suggests, and it implies a compound with real effects.

The mechanism is the other draw. The literature describes increases in BDNF and NGF, proteins that support the growth and maintenance of neurons, which is a more interesting story than a stimulant.

What people take it for#

Concentration, mental stamina and memory, particularly among students and people doing demanding cognitive work.

Focus and mental stamina#

The claim is sustained concentration through long cognitive work. The mechanism described in the literature involves the neurotrophins above, along with effects on dopamine and serotonin systems.

In practice that describes supporting the machinery neurons use to stay healthy and to adapt. This has been measured in animals and in clinical populations after stroke.

Memory and learning#

The claim is that things are learned and recalled more easily, on the same neurotrophic activity, which in animal models is associated with better performance on learning tasks.

Animal work supports the direction. No trial in healthy people has measured it.

Recovery after stroke or brain injury#

This is the clinical use in Russia and the one with the most substantial evidence behind it. Trials there report improved outcomes when it is given after ischaemic stroke.

That population is nothing like a healthy adult buying a nasal spray for focus, and results do not transfer between them.

What the evidence shows#

Russian trials report benefits after stroke and effects on BDNF. Animal work supports neuroprotective activity.

The same caveat as Selank applies, and it is the important one: the evidence base sits almost entirely within one country's literature and has not been replicated by independent groups elsewhere. Nothing about that makes it false, and it does mean nobody outside that system has checked.

For healthy adults wanting sharper focus specifically, there is no good trial. Reported effects are mild and mostly local: nasal irritation, occasional headache, sometimes difficulty sleeping if used late in the day.

How it is taken#

The Russian product is a nasal spray, used in courses of days to a few weeks rather than continuously. What is sold elsewhere is usually a compounded spray, sometimes N-acetyl semax amidate, a modified version claimed to last longer and with less published work behind it.

Continuous use is common in practice and has not been studied.

How it compares#

Against Selank#

Selank comes from the same programme and targets anxiety rather than cognition. The evidence situation is identical, and the two are frequently sold together.

Against the alternatives for cognition#

There are no licensed drugs for improving cognition in healthy adults anywhere, which is worth stating plainly rather than treating as a gap this fills. Sleep, exercise and treating an underlying problem remain the interventions with the strongest evidence.

Common questions#

Is N-acetyl semax different?

It is a modified version marketed as longer-acting, with less published research than the original.

Does it work for healthy people?

No trial has shown that. The clinical evidence concerns people recovering from stroke, which is a different question.

How long is a course?

Russian protocols describe days to a few weeks rather than continuous use.

Why nasal rather than oral?

A short peptide would not survive digestion. The nasal route gets it into circulation intact.